Home LiteratureArticle Details
PMID: 4355208 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial

Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man.

The Journal of infectious diseases ·Vol. 128 ·No. 4 ·1973-10-00 ·Pages 500-5

Schwartz AR, Togo Y, Hornick RB, Tominaga S, Gleckman RA

Abstract

暂无摘要

MeSH Terms
Adult Ascorbic Acid/adverse effects,blood,pharmacology,therapeutic use,urine Clinical Trials as Topic Common Cold/microbiology,prevention & control Humans Male Middle Aged Placebos Rhinovirus/drug effects
Chemicals
Placebos Ascorbic Acid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Schwartz A R
Togo Y
Hornick R B
Tominaga S
Gleckman R A
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
DOI
10.1093/infdis/128.4.500
Published
1973-10-00
Pages
500-5
Language
English
Region
United States
NLM ID
0413675
Subset
IM
External Links
PubMed source DOI: 10.1093/infdis/128.4.500 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2